Probucol decreases total body fat loss in VX2-carcinoma-induced cachectic rabbits

Oncol Rep. 2001 Nov-Dec;8(6):1309-11. doi: 10.3892/or.8.6.1309.

Abstract

We previously reported the continuous decrease of total body fat in VX2-carcinoma-bearing rabbits after tumor implantation, as well as changes in the serum lipid profile. Probucol, an antioxidant drug, has a cholesterol lowering effect against hyperlipidemic subjects. VX2-carcinoma-bearing rabbits fed with a diet containing 1% probucol did not show any difference in serum lipid compositions as compared with rabbits fed with a control diet. Similarly serum lipolytic activity showed no differences, whether probucol was administered or not, while the decrease in total body fat was significantly less when probucol was administered.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adipose Tissue / drug effects*
  • Adipose Tissue / metabolism
  • Animals
  • Anticholesteremic Agents / pharmacology*
  • Antioxidants / pharmacology*
  • Cachexia / etiology*
  • Cachexia / metabolism
  • Lipids / blood
  • Male
  • Neoplasm Transplantation
  • Neoplasms / physiopathology*
  • Probucol / pharmacology*
  • Rabbits

Substances

  • Anticholesteremic Agents
  • Antioxidants
  • Lipids
  • Probucol